World Next Generation Sequencing Market Grows at 21% CAGR to 2019 Forecasts a New Research Report

Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.

The analysts forecast global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:

  • Commercial entities such as hospitals and pharmaceutical and life sciences companies
  • Research institutes

The report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Purchase a copy of the report at .

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Illumina
  • Roche Diagnostics
  • Thermo Fischer Scientific

Other Prominent Vendors

  • 10X Genomics
  • 23andMe
  • Ambry Genetics
  • Axeq Technologies
  • Beijing Genomics Institute
  • CLC bio
  • Clontech Laboratories
  • Fluidigm
  • Foundation Medicine
  • GATC Biotech
  • GeneDx
  • Gnomegen
  • Good Start Genetics
  • Ingenuity Systems
  • Knome
  • NABsys
  • Oxford Nanopore Technologies
  • Pathogenica
  • PerkinElmer
  • RainDance Technologies
  • Rubicon Genomics
  • Sequenom
  • Sigma-Aldrich
  • Source Biosciences
  • Takara Bio

Market Driver

  • Increased Adoption by New Customers

Market Challenge

  • Technical and Implementation Issues

Market Trend

  • Strategic Alliances

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

For more Information on the report, inquire at .

About US:   ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.